Welcome to our dedicated page for APN news (Ticker: APN), a resource for investors and traders seeking the latest updates and insights on APN stock.
Apeiron Capital Investment Corp. (APN) is a blank check company established with the primary goal of executing mergers, capital stock exchanges, asset acquisitions, stock purchases, reorganizations, or similar business combinations. Under the leadership of Chief Executive Officer Dr. Joel Shulman, the company has navigated various business ventures and strategic decisions to maximize shareholder value.
As of August 11, 2023, Apeiron Capital Investment Corp. announced its decision to terminate the Business Combination Agreement with GIO World Health, Ltd. Due to the inability to complete an initial business combination within the required timeframe, the company will liquidate and dissolve effective August 14, 2023. This decision will lead to the redemption of all outstanding public shares at a per-share price determined by the trust account funds, excluding up to $100,000 allocated for dissolution expenses. Public shares will be deemed canceled and holders will receive their redemption amounts shortly after the termination date.
The company has instructed the trustee to liquidate the trust account, with proceeds held in a non-interest bearing account until disbursement to shareholders. Founder shares issued during the initial public offering will not be redeemed, and the company's warrants will expire worthless under the current plan.
Apeiron Capital Investment Corp. has always aimed to provide transparent and effective communication with its investors. The company’s forward-looking statements have outlined potential business combinations and financing plans, which have been subject to various market conditions and regulatory factors.
With a focus on shareholder value and diligent financial management, Apeiron Capital Investment Corp. remains committed to adhering to regulatory standards and fulfilling its obligations to its stakeholders as it transitions through the liquidation process.
GIO World Health Ltd has announced a business combination agreement with Apeiron Capital Investment Corp (APNC) to take GIO public, valuing the company at a pre-money enterprise value of $250 million. Post-closing, current GIO shareholders will maintain 100% equity and approximately 80.83% ownership in the combined entity, which will be named GIO World Health Holdings, Inc. The transaction aims to provide a platform for GIO's stem cell treatments and other products. The deal is anticipated to close in the second half of 2023, pending shareholder approvals and customary conditions.
Apeiron Capital Investment Corp. (NYSE: APN U) announced on December 29, 2021, that starting December 30, holders of its IPO units can separately trade shares of Class A common stock (symbol: APN) and warrants (symbol: APN W). No fractional warrants will be issued upon separation, and the units that remain unseparated will continue trading under the symbol APN U. The Company is a blank check firm aiming for mergers or acquisitions, primarily in the financial technology, media, gaming, and wealth-advisory sectors.
Apeiron Capital Investment Corp. closed its IPO of 17,250,000 units at $10.00 each, including the full exercise of the underwriters' over-allotment option. The units began trading on the NYSE under the ticker symbol 'APNU' on November 9, 2021. Each unit comprises one share of Class A common stock and one-half of a redeemable warrant, with each whole warrant exercisable at $11.50 per share. The Company aims for business combinations mainly in financial technology, media, gaming, and wealth-advisory sectors.
Apeiron Capital Investment Corp. announced the pricing of its initial public offering (IPO) of 15,000,000 units at $10.00 per unit, set to begin trading on the NYSE under the ticker APN U on November 9, 2021. Each unit comprises one share of Class A common stock and one-half of a redeemable warrant, with whole warrants exercisable at $11.50 per share. The offering is expected to close on November 12, 2021, pending customary conditions. The company intends to focus on mergers in the FTMG sectors, while Cantor Fitzgerald serves as the offering manager.
FAQ
What is the market cap of APN (APN)?
What is Apeiron Capital Investment Corp. (APN)?
Who is the CEO of Apeiron Capital Investment Corp.?
Why is Apeiron Capital Investment Corp. liquidating?
What happens to the public shares after liquidation?
Will the company's warrants have any value after liquidation?
Do shareholders need to take any action to receive the redemption amount?
What is the expected timeline for the redemption process?
Will founder shares be redeemed during the liquidation process?
What is the purpose of the trust account liquidation?
How can I contact Apeiron Capital Investment Corp. for more information?
